• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·MDCN
Share

Medican Enterprises, Inc. Stocks

$ 0Last Updated 23.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 2.88M

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Medican Enterprises, Inc. focuses on sports and entertainment investments, holding stakes in basketball franchises, digital media assets, and sports-related non-fungible tokens (NFTs). The company offers basketball team ownership, sports real estate interests, media content, and digital collectibles. It also manages and develops basketball teams; produces and licenses sports-related media content, including documentaries, video games, and digital content; creates and manages NFTs and other digital collectibles; and provides strategic investment opportunities and consulting services. Medican Enterprises, Inc. was incorporated in 1988 and is headquartered in Las Woodland Hills, California.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 18:00

Black Cyber October: AI Has Eliminated the Hacker Shortage. How Is the Market Responding?

27.10.2026 17:26

The AI bubble has burst in the world's second-largest stock market. What triggered it?

27.10.2026 17:18

Nvidia will invest $3 billion in Meta stock. The companies will expand their work on AI agents

27.10.2026 16:57

Revolut Is Under Scrutiny Again Due to Its Rapid Product Rollouts — FT

27.10.2026 16:50

"Investors Are Taking Out Their Frustration": PagSeguro's Fintech Shares Have Plummeted. Is It Time to Buy?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026